Ross Baldessarini, MD
Professor of psychiatry and neuroscience, Harvard Medical School, Boston, MA; Director, psychopharmacology program & International Consortium for Bipolar Disorder Research, McLean Hospital, Belmont, MA
Dr. Baldessarini has disclosed that he has recently been a paid consultant to Alkermes, Inc., a comarketer of Risperdal Consta and VIVITROL (a monthly injectable form of naloxone for alcohol and opioid dependence). Dr. Carlat reviewed this article and found that there is no evidence of commercial bias in this educational activity.
You started a stimulant medication for a young woman with ADHD. When she returns her symptoms are 70% better, but what can we do about the rest? Today a conversation with...